Breast cancer is commonly classified based on the expression of different receptors: estrogen and/or progesterone receptors (ER/PR +), amplification or overexpression of human epidermal growth factor 2 (HER2 +), or the absence of all three markers, which defines triple negative breast cancer (TNBC). This evidence concerns the gene PGR and breast cancer.